Browsing by Author "Singh, Rohit"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Publication
    A Study Of Reading Habits Among The Senior Secondary Students Of Kendriya Vidyalaya In Varanasi, Uttar Pradesh
    (University of Idaho Library, 2021) Singh, Rohit; Singh, Ashwani
    The purpose of this paper is to report the finding of the study of reading habits among the senior secondary student of three Kendriya Vidyalaya (KV) school of Varanasi district run by the Ministry of Education, Government of India. The study adopts the questionnaire tool & 300 questionnaires are distributed to collect the data from the student to examine the choice of reading material, preferred place, language & source of getting reading materials. Collected data indicates that the English language is the most preferred language for reading; textbook, newspaper magazines are the most preferred reading material. School is the most preferred place of reading; the Internet is a major source of getting reading material followed by the library & home. School assignments are a major reason for reading. This study has practical implications for library professionals to identify factors hindering the reading habits of students finding indicates that however the internet is a major source of getting reading materials but the majority of students prefer printed materials over electronic reading Material. � 2021. All Rights Reserved
  • Thumbnail Image
    Publication
    Acute Cardiac Events After ChAdOx1 nCoV-19 Corona Virus Vaccine: Report of Three Cases
    (Lippincott Williams and Wilkins, 2022) Singh, Rohit; Chakrabarti, Sankha Shubhra; Gambhir, Indrajeet Singh; Verma, Ashish; Kumar, Ishan; Ghosh, Soumik; Tiwari, Ashutosh; Chandan, Gourav; Chakrabarti, Sasanka; Kaur, Upinder
    [No abstract available]
  • Thumbnail Image
    Publication
    Case Report: Isoniazid-Associated Delirium in an Elderly Female with Spinal Tuberculosis
    (American Society of Tropical Medicine and Hygiene, 2022) Kaur, Upinder; Singh, Rohit; Singh, Amit; Chakrabarti, Sankha Shubhra
    Isoniazid is an important component of first-line antitubercular therapy. The drug at its therapeutic dose is known to cause hepatitis and peripheral neuropathy. The association of isoniazid with pure delirium is rare. Here, we present an interesting case of new-onset delirium associated with isoniazid in an elderly female with spinal tuberculosis. Remarkable improvement was noticed in the patient following drug discontinuation and pyridoxine augmentation. Copyright � 2022 by The American Society of Tropical Medicine and Hygiene.
  • Thumbnail Image
    Publication
    Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India
    (MDPI, 2022) Kaur, Upinder; Bala, Sapna; Joshi, Aditi; Reddy, Noti Taruni Srija; Japur, Chetan; Chauhan, Mayank; Pedapanga, Nikitha; Kumar, Shubham; Mukherjee, Anurup; Mishra, Vaibhav; Talda, Dolly; Singh, Rohit; Gupta, Rohit Kumar; Yadav, Ashish Kumar; Rana, Poonam Jyoti; Srivastava, Jyoti; Bhat K, Shobha; Singh, Anup; Naveen Kumar P., G.; Pandey, Manoj; Patwardhan, Kishor; Kansal, Sangeeta; Chakrabarti, Sankha Shubhra
    Background There is paucity of real-world data on COVID-19 vaccine effectiveness from cohort designs. Variable vaccine performance has been observed in test-negative case-control designs. There is also scarce real-world data of health issues in individuals receiving vaccines after prior COVID-19, and of adverse events of significant concern (AESCs) in the vaccinated. Methods: A cohort study was conducted from July 2021 to December 2021 in a tertiary hospital of North India. The primary outcome was vaccine effectiveness against COVID-19 during the second wave in India. Secondary outcomes were AESCs, and persistent health issues in those receiving COVID-19 vaccines. Regression analyses were performed to determine risk factors of COVID-19 outcomes and persistent health issues. Results: Of the 2760 health care workers included, 2544 had received COVID-19 vaccines, with COVISHIELD (rChAdOx1-nCoV-19 vaccine) received by 2476 (97.3%) and COVAXIN (inactivated SARS-CoV-2 vaccine) by 64 (2.5%). A total of 2691 HCWs were included in the vaccine effectiveness analysis, and 973 COVID-19 events were reported during the period of analysis. Maximum effectiveness of two doses of vaccine in preventing COVID-19 occurrence was 17% across three different strategies of analysis adopted for robustness of data. One-dose recipients were at 1.27-times increased risk of COVID-19. Prior SARS-CoV-2 infection was a strong independent protective factor against COVID-19 (aOR 0.66). Full vaccination reduced moderate�severe COVID-19 by 57%. Those with lung disease were at 2.54-times increased risk of moderate�severe COVID-19, independent of vaccination status. AESCs were observed in 33/2544 (1.3%) vaccinees, including one case each of myocarditis and severe hypersensitivity. Individuals with hypothyroidism were at 5-times higher risk and those receiving a vaccine after recovery from COVID-19 were at 3-times higher risk of persistent health issues. Conclusions: COVID-19 vaccination reduced COVID-19 severity but offered marginal protection against occurrence. The possible relationship of asthma and hypothyroidism with COVID-19 outcomes necessitates focused research. With independent protection of SARS-CoV-2 infection, and high-risk of persistent health issues in individuals receiving vaccine after recovery from SARS-CoV-2 infection, the recommendation of vaccinating those with prior SARS-CoV-2 infection needs reconsideration. � 2022 by the authors.
  • Thumbnail Image
    Publication
    Refractory hypereosinophilia associated with newly diagnosed rheumatoid arthritis following inactivated BBV152 COVID-19 vaccine
    (John Wiley and Sons Inc, 2022) Singh, Rohit; Kaur, Upinder; Singh, Ankur; Chakrabarti, Sankha S.
    [No abstract available]